journal
Journals Current Treatment Options in P...

Current Treatment Options in Psychiatry

https://read.qxmd.com/read/33723500/repetitive-transcranial-magnetic-stimulation-for-treatment-resistant-depression-recent-critical-advances-in-patient-care
#21
REVIEW
Camila Cosmo, Amin Zandvakili, Nicholas J Petrosino, Yosef A Berlow, Noah S Philip
PURPOSE: Transcranial magnetic stimulation (TMS) is an evidence-based treatment for pharmacoresistant major depressive disorder (MDD). In the last decade, the field has seen significant advances in the understanding and use of this new technology. This review aims to describe the large, randomized controlled studies leading to the modern use of rTMS for MDD. It also includes a special section briefly discussing the use of these technologies during the COVID-19 pandemic. RECENT FINDINGS: Several new approaches and technologies are emerging in this field, including novel approaches to reduce treatment time and potentially yield new approaches to optimize and maximize clinical outcomes...
2021: Current Treatment Options in Psychiatry
https://read.qxmd.com/read/35444925/ptsd-substance-use-disorder-comorbidity-treatment-options-and-public-health-needs
#22
JOURNAL ARTICLE
Lisa M Najavits, H Westley Clark, Carlo C DiClemente, Marc N Potenza, Howard J Shaffer, James L Sorensen, Matthew T Tull, Allen Zweben, Joan E Zweben
Purpose of Review: Posttraumatic stress disorder (PTSD) commonly co-occurs with substance use disorder (SUD) and is challenging to treat. We review all behavioral therapy models with at least one randomized controlled trial in a current PTSD/SUD population. We identify factors in selecting a model for clinical use, emphasizing a public health framework that balances the need for evidence with the need for feasibility in frontline settings. Recent Findings: Seven published models and 6 unpublished models are reviewed...
December 2020: Current Treatment Options in Psychiatry
https://read.qxmd.com/read/33643770/positive-psychiatry-interventions-in-geriatric-mental-health
#23
JOURNAL ARTICLE
Jeffrey Lam, Awais Aftab, Ellen Lee, Dilip Jeste
Purpose of review: Positive psychiatry shifts the focus of geriatric mental healthcare beyond studying disorders and psychopathology to studying factors that contribute to mental well-being and successful aging. An increasing number of interventional studies are using treatments that target modifiable positive psychosocial characteristics (PPCs) and study their impact on mental health. Here we provide an overview of the literature on positive psychiatry interventions using illustrative examples of interventions targeting social connectedness, meaning in life, wisdom, and resilience...
December 2020: Current Treatment Options in Psychiatry
https://read.qxmd.com/read/33344107/pharmacological-management-of-neuropsychiatric-symptoms-of-dementia
#24
JOURNAL ARTICLE
Lauren B Gerlach, Helen C Kales
PURPOSE: Neuropsychiatric symptoms are universal across all stages and types of dementia and can cause significant challenges for patients and caregivers. While there are currently no approved medications for treatment of neuropsychiatric symptoms of dementia, a variety of psychotropic medications such as antipsychotics, benzodiazepines, anticonvulsants, and antidepressants are used off-label to treat these symptoms. This systematic review evaluated the available evidence for effectiveness and tolerability of pharmacologic treatments in addressing behavioral disturbances in dementia...
December 2020: Current Treatment Options in Psychiatry
https://read.qxmd.com/read/33585165/buprenorphine-dosing-for-the-treatment-of-opioid-use-disorder-through-pregnancy-and-postpartum
#25
JOURNAL ARTICLE
Caitlin E Martin, Caroline Shadowen, Bhushan Thakkar, Travis Oakes, Tamas S Gal, F Gerard Moeller
Purpose of Review: Opioid-related deaths are a leading cause of mortality during pregnancy through 12 months postpartum. Buprenorphine use during pregnancy is increasing, yet expert opinion on its dosing through the perinatal period is limited. We provide a review of the current clinical literature on buprenorphine dosing during pregnancy through 12 months postpartum. and present data from a retrospective chart review of patients at our institution describing trends in buprenorphine dosing during pregnancy and postpartum...
September 2020: Current Treatment Options in Psychiatry
https://read.qxmd.com/read/33585164/the-efficacy-and-safety-of-neuromodulation-treatments-in-late-life-depression
#26
JOURNAL ARTICLE
Sanne J H van Rooij, Patricio Riva-Posse, William M McDonald
PURPOSE OF REVIEW: In this review, the efficacy and safety of FDA approved neuromodulation devices (electroconvulsive therapy (ECT), transcranial magnetic stimulation (TMS) and vagus nerve stimulation (VNS)), as well as emerging neuromodulation treatments currently under investigation. RECENT FINDINGS: ECT is the "gold standard" somatic therapy for treatment resistant depression (TRD). Although the clinical benefits are outweighed by potential cognitive and cardiovascular side effects in majority of cases, it remains unfairly stigmatized...
September 2020: Current Treatment Options in Psychiatry
https://read.qxmd.com/read/33552844/treatment-of-sleep-comorbidities-in-posttraumatic-stress-disorder
#27
JOURNAL ARTICLE
Janeese A Brownlow, Katherine E Miller, Philip R Gehrman
Purpose of the review: Sleep disturbances, insomnia and recurrent nightmares in particular, are among the most frequently endorsed symptoms of posttraumatic stress disorder (PTSD). The present review provides a summary of the prevalence estimates and methodological challenges presented by sleep disturbances in PTSD, highlights the recent evidence for empirically supported psychotherapeutic and pharmacological interventions for comorbid sleep disturbances implicated in PTSD, and provides a summary of recent findings on integrated and sequential treatment approaches to ameliorate comorbid sleep disturbances in PTSD...
September 2020: Current Treatment Options in Psychiatry
https://read.qxmd.com/read/32904865/emerging-complementary-and-integrative-therapies-for-geriatric-mental-health
#28
REVIEW
Sarah A Nguyen, Helen LAvretsky
Purpose: The use of complementary and integrative medicine (CIM) is on the rise among diverse populations of older adults in the USA. CIM is commonly perceived as safer, less expensive, and more culturally acceptable. There is a growing body of evidence to support the use of CIM, especially mind-body therapies, diet and nutritional supplements used for mental disorders of aging. Recent findings: We summarize the results of the recent clinical trials and meta-analyses that provide the evidence for the role of CIM in treating older adults with mood or cognitive disorders that includes the use of diet and supplements, and mind-body therapies...
September 1, 2020: Current Treatment Options in Psychiatry
https://read.qxmd.com/read/33344106/predicting-and-managing-treatment-non-response-in-posttraumatic-stress-disorder
#29
JOURNAL ARTICLE
Gregory A Fonzo, Vecheslav Federchenco, Alba Lara
Purpose of Review: This review aims to synthesize existing research regarding the definition of treatment resistance in posttraumatic stress disorder (PTSD), predictors of treatment non-response to first-line interventions, and emerging second-line PTSD treatment options into an accessible resource for the practicing clinician. Recent Findings: The concept of treatment resistance in PTSD is currently poorly defined and operationalized. There are no well-established predictors of treatment non-response utilized in routine clinical care, but existing research identifies several potential candidate markers, including male gender, low social support, chronic and early life trauma exposure, comorbid psychiatric disorders, severe PTSD symptoms, and poor physical health...
June 2020: Current Treatment Options in Psychiatry
https://read.qxmd.com/read/32714742/cannabis-and-the-developing-adolescent-brain
#30
JOURNAL ARTICLE
Adina S Fischer, Susan F Tapert, Dexter Lee Louie, Alan F Schatzberg, Manpreet K Singh
PURPOSE OF REVIEW: This review summarizes (1) recent trends in delta-9-tetrahydrocannabionol [THC] and cannabidiol (CBD) content in cannabis products, (2) neurobiological correlates of cannabis use on the developing adolescent brain, (3) effects of cannabis on psychiatric symptoms and daily functioning in youth (i.e., academic performance, cognition, sleep and driving), (4) cannabis products used to relieve or treat medical issues in youth, and (5) available treatments for cannabis use disorder in adolescence...
June 2020: Current Treatment Options in Psychiatry
https://read.qxmd.com/read/32837831/advances-in-ptsd-treatment-delivery-review-of-findings-and-clinical-considerations-for-the-use-of-telehealth-interventions-for-ptsd
#31
REVIEW
Leslie A Morland, Stephanie Y Wells, Lisa H Glassman, Carolyn J Greene, Julia E Hoffman, Craig S Rosen
Purpose of review: Effective treatments for posttraumatic stress disorder (PTSD) remain underutilized and individuals with PTSD often have difficulty accessing care. Telehealth, particularly clinical videoconferencing (CVT), can overcome barriers to treatment and increase access to care for individuals with PTSD. The purpose of this review is to summarize the literature on the delivery of PTSD treatments through office-based and home-based videoconferencing, and outline areas for future research...
May 30, 2020: Current Treatment Options in Psychiatry
https://read.qxmd.com/read/32837830/engaging-in-late-life-mental-health-research-a-narrative-review-of-challenges-to-participation
#32
REVIEW
Jordyn Newmark, Marie Anne Gebara, Howard Aizenstein, Jordan F Karp
Purpose of review: This narrative review seeks to ascertain the challenges older patients face with participation in mental health clinical research studies and suggests creative strategies to minimize these obstacles. Recent findings: Challenges to older adults' engagement in mental health research include practical, institutional, and collaboration-related barriers applicable to all clinical trials as well as more personal, cultural, and age-related patient barriers specific to geriatric mental health research...
May 22, 2020: Current Treatment Options in Psychiatry
https://read.qxmd.com/read/32292687/telemental-health-in-the-context-of-a-pandemic-the-covid-19-experience
#33
REVIEW
Emile Whaibeh, Hossam Mahmoud, Hady Naal
No abstract text is available yet for this article.
April 2, 2020: Current Treatment Options in Psychiatry
https://read.qxmd.com/read/32421099/addressing-diversity-in-ptsd-treatment-clinical-considerations-and-guidance-for-the-treatment-of-ptsd-in-lgbtq-populations
#34
REVIEW
Nicholas A Livingston, Danielle Berke, James Scholl, Mollie Ruben, Jillian C Shipherd
Purpose of review: Trauma exposure is widespread but is especially common among lesbian, gay, bisexual, transgender, and queer (LGBTQ) individuals. LGBTQ individuals also experience higher rates of discrimination, victimization, and minority stress which can complicate posttraumatic stress disorder (PTSD) treatment but also represent independent intervention targets. In this review, we highlight existing evidence-based practices, current limitations, and provide recommendations for care in the absence of established guidelines for treatment PTSD among LGBTQ patients...
March 16, 2020: Current Treatment Options in Psychiatry
https://read.qxmd.com/read/33312841/new-somatic-treatments-for-child-and-adolescent-depression
#35
JOURNAL ARTICLE
Kathryn R Cullen, Laura E Padilla, Victoria N Papke, Bonnie Klimes-Dougan
Purpose of Review: Depression is a common clinical problem in youth, with prevalence increasing significantly during the adolescent period. Although several evidence-based treatments are currently available for treating depression in adults, only a subset of these have been investigated in a pediatric sample. Unfortunately, even well-established, first-line interventions do not lead to sufficient treatment response for many children and adolescents suffering from depression. However, recent research has been conducted in the area of somatic treatments for youth with depression...
December 2019: Current Treatment Options in Psychiatry
https://read.qxmd.com/read/32754423/a-systematic-review-of-treatment-options-for-grieving-older-adults
#36
JOURNAL ARTICLE
Kailey E Roberts, Leah E Walsh, Rebecca M Saracino, Justin Fogarty, Taylor Coats, Johanna Goldberg, Holly Prigerson, Wendy G Lichtenthal
Purpose of review: a)The purpose of this systematic review was to characterize the studies published on grief interventions for bereaved older adults in the last 5 years. Grief intervention studies were included that exclusively focused on older adults as well as those that included older adults in their samples, in order to summarize the most up-to-date treatment options available for bereaved older adults. Recent findings: b)Twenty-four articles that investigated grief interventions in older adults were identified...
December 2019: Current Treatment Options in Psychiatry
https://read.qxmd.com/read/32457823/digital-innovations-for-global-mental-health-opportunities-for-data-science-task-sharing-and-early-intervention
#37
JOURNAL ARTICLE
John A Naslund, Pattie P Gonsalves, Oliver Gruebner, Sachin R Pendse, Stephanie L Smith, Amit Sharma, Giuseppe Raviola
Purpose: Globally, individuals living with mental disorders are more likely to have access to a mobile phone than mental health care. In this commentary, we highlight opportunities for expanding access to and use of digital technologies to advance research and intervention in mental health, with emphasis on the potential impact in lower resource settings. Recent findings: Drawing from empirical evidence, largely from higher income settings, we considered three emerging areas where digital technology will potentially play a prominent role: supporting methods in data science to further our understanding of mental health and inform interventions, task sharing for building workforce capacity by training and supervising non-specialist health workers, and facilitating new opportunities for early intervention for young people in lower resource settings...
December 2019: Current Treatment Options in Psychiatry
https://read.qxmd.com/read/33796435/the-future-of-peer-support-in-digital-psychiatry-promise-progress-and-opportunities
#38
JOURNAL ARTICLE
Karen L Fortuna, Maria Venegas, Emre Umucu, George Mois, Robert Walker, Jessica M Brooks
Purpose: This selective review highlights promising findings and future opportunities relevant to digital peer support services. This review considered literature published in peer-reviewed scholarly journals within the past 36 months. Recent findings: Digital peer support spans multiple technology modalities: peer-delivered and smartphone-supported interventions, peer-supported asynchronous technology, artificial peer support, informal peer-to-peer support via social media, video games, and virtual worlds...
September 2019: Current Treatment Options in Psychiatry
https://read.qxmd.com/read/31886118/dealing-with-complexity-and-comorbidity-opportunity-for-transdiagnostic-treatment-for-ptsd
#39
JOURNAL ARTICLE
Cassidy A Gutner, Candice Presseau
Purpose of Review: This review synthesizes literature on transdiagnostic treatments for PTSD and trauma-related psychopathology over the last three years and discusses their across diverse contexts. Recent Findings: Global and domestic studies suggest that a transdiagnostic approach has the potential to address many challenges providers encounter when treating traumatized populations. Existing research shows that transdiagnostic approaches (including the Unified Protocol, Common Elements Treatment Approach, and Modular Approach to Therapy for Children) are effective across low and high resourced settings, populations, and with comorbid mental health symptoms...
June 2019: Current Treatment Options in Psychiatry
https://read.qxmd.com/read/31763133/augmenting-treatment-for-posttraumatic-stress-disorder-and-co-occurring-conditions-with-oxytocin
#40
JOURNAL ARTICLE
Julianne C Flanagan, Jennifer M Mitchell
PURPOSE OF REVIEW: The goal of this manuscript is to review the extant literature examining the neurobiological and behavioral mechanisms underlying the potential utility of intranasal oxytocin as a novel pharmacologic intervention for the treatment of posttraumatic stress disorder (PTSD), and for the treatment of co-morbid PTSD and alcohol and substance use disorders. RECENT FINDINGS: Research indicates that intranasal oxytocin is a low-cost and easily accessible medication with an excellent safety profile...
June 2019: Current Treatment Options in Psychiatry
journal
journal
48804
2
3
Fetch more papers »
Fetching more papers... Fetching...
Remove bar
Read by QxMD icon Read
×

Save your favorite articles in one place with a free QxMD account.

×

Search Tips

Use Boolean operators: AND/OR

diabetic AND foot
diabetes OR diabetic

Exclude a word using the 'minus' sign

Virchow -triad

Use Parentheses

water AND (cup OR glass)

Add an asterisk (*) at end of a word to include word stems

Neuro* will search for Neurology, Neuroscientist, Neurological, and so on

Use quotes to search for an exact phrase

"primary prevention of cancer"
(heart or cardiac or cardio*) AND arrest -"American Heart Association"

We want to hear from doctors like you!

Take a second to answer a survey question.